BEGIN:VCALENDAR VERSION:2.0 PRODID:-//BioCT - ECPv6.3.3.1//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:BioCT X-ORIGINAL-URL:https://bioct.org X-WR-CALDESC:Events for BioCT REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20220313T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20221106T060000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;VALUE=DATE:20220214 DTEND;VALUE=DATE:20220218 DTSTAMP:20240329T034924 CREATED:20211202T144506Z LAST-MODIFIED:20211202T144506Z UID:5262-1644796800-1645142399@bioct.org SUMMARY:BIO CEO & Investor Conference DESCRIPTION:For more than 20 years\, the BIO CEO & Investor Conference has fueled the biotech industry networking with premier investor and banking communities\, focused on established and emerging publicly traded and select private biotech companies. \nJoin us in 2022 – either in person or online – for one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies\, where institutional investors\, industry analysts\, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry. URL:https://bioct.org/event/bio-ceo-investor-conference/ LOCATION:New York Marriott Marquis & Virtual CATEGORIES:BIO END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20220217T110000 DTEND;TZID=America/New_York:20220217T120000 DTSTAMP:20240329T034924 CREATED:20220119T195529Z LAST-MODIFIED:20220119T195605Z UID:5497-1645095600-1645099200@bioct.org SUMMARY:huNOG-EXL EA (Early Access): A Myeloid-Supportive HIS Model with a Longer Potential Study Window - Hosted by Taconic DESCRIPTION:Join us for an informative webinar discussing the advantages of utilizing Taconic Biosciences’ huNOG-EXL EA option for research studies. \nThe huNOG-EXL is a versatile humanized immune system mouse which supports development of both lymphoid and myeloid cells. The new huNOG-EXL EA option allows more flexibility in study design\, particularly for certain challenging scenarios. \nDuring this webinar\, you’ll gain an understanding of how inter- and intra-donor variability can impact experimental outcomes and how Taconic controls for these in humanized mice production. \nThe huNOG-EXL EA model can: \n\n\n\n\n\n\n\n\n\n\n\n\nMaximize the possible study window for huNOG-EXL mice\nProvide a sufficient study window for efficacy studies using slow-growing tumors or with longer treatment paradigms\nAllow for the start of experimentation in huNOG-EXL mice prior to emergence of T cells or during the peak B cell period\nOvercome unavoidable logistics and quarantine challenges\, which may reduce the study window unacceptablely when using the standard huNOG-EXL offering URL:https://bioct.org/event/hunog-exl-ea-early-access-a-myeloid-supportive-his-model-with-a-longer-potential-study-window-hosted-by-taconic/ LOCATION:VIRTUAL END:VEVENT END:VCALENDAR